Human immunodeficiency virus protease inhibitors serve as substrates for multidrug transporter proteins MDR1 and MRP1 but retain antiviral efficacy in cell lines expressing these transporters

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 12, 1998, Pages 3157-3162

  Srinivas, Ranga V ^a   Middlemas, David ^a   Flynn, Pat ^a   Fridland, Arnold ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CALCEIN; DOXORUBICIN; GLYCOPROTEIN P; INDINAVIR; NELFINAVIR; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG EFFICACY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEINASE INHIBITION; T LYMPHOCYTE ACTIVATION; VIRUS EXPRESSION; VIRUS REPLICATION;

EID: 0031788927     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.12.3157     Document Type: Article

References (35)

1. Alsenz, J., H. Steffen, and R. Alex. 1998. Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in caco-2 cell monolayers. Pharm. Res. 15:423-428.
2. Andreana, A., S. Aggarwal, S. Gollapudi, D. Wien, T. Tsuruo, and S. Gupta. 1996. Abnormal expression of a 170 kilodalton P-glycoprotein encoded by MDR1 gene, a metabolically active efflux pump, in CD4+ and CD8+ T cells from patients with human immunodeficiency virus type 1 infection. AIDS Res. Hum. Retroviruses 12:1457-1462.
3. Barry, M., S. Gibbons, D. Back, and F. Mulcahy. 1997. Protease inhibitors in patients with HIV disease. Clin. Pharmacokinet. 32:194-209.
4. Beck, W. T. 1983. Vinca alkaloid-resistant phenotype in cultured human leukemic lymphoblasts. Cancer Treat. Rep. 67:875-882.
5. Beck, W. T., and M. C. Cirtain. 1982. Continued expression of vinca alkaloid resistance by CCRF-CEM cells after treatment with tunicamycin or pronase. Cancer Res. 42:184-189.
6. Borst, P. 1997. Multidrug resistant proteins. Semin. Cancer Biol. 8:131-134.
7. Cole, S. P., and R. G. Deeley. 1996. Multidrug resistance associated with overexpression of MRP. Cancer Treat. Res. 87:39-62.
8. Condra, J. H., W. A. Schleif, O. M. Blahy, L. J. Gabryelski, D. J. Graham, J. C. Quintero, A. Rhodes, H. L. Robbins, E. Roth, M. Shivaprakash, et al. 1995. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors. Nature 374:569.
9. Danks, M. K., J. C. Yalowich, and W. T. Beck. 1987. Atypical multiple drug resistance human leukemic cell line selected for resistance to teniposide (VM-26). Cancer Res. 47:1297-1301.
10. Dey, S., M. Ramachandra, I. Pastan, M. M. Gottesman, and S. V. Ambudkar. 1997. Evidence for two nonidentical drug-interaction sites in the human P-glycoprotein. Proc. Natl. Acad. Sci. USA 94:10594-10599.
11. Feller, N., C. M. Kuiper, J. Lankelma, J. K. Ruhdal, R. J. Scheper, H. M. Pinedo, and H. J. Broxterman. 1995. Functional detection MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry. Br. J. Cancer 72:543-549.
12. Goldstein, L. J., I. Pastan, and M. M. Gottesman. 1992. Multidrug resistance in human cancer. Crit. Rev. Oncol.-Hematol. 12:243-253.
13. Goodfellow, H. R., A. Sardini, S. Ruetz, R. Callaghan, P. Gros, P. A. McNaughton, and C. F. Higgins. 1996. Protein kinase C-mediated phosphorylation does not regulate drug transport by the human multidrug resistance P-glycoprotein. J. Biol. Chem. 271:13668-13674.
14. Hollo, Z., L. Homolya, C. W. Davis, and B. Sarkardi. 1994. Calcein accumulation as a fluorometric functional assay of the multidrug transporter. Biochim. Biophys. Acta 1191:384.
15. Homolya, L., M. Hollo, M. Muller, E. B. Mechetner, and B. Sarkadi. 1996. A new method for a quantitative assessment of P-glycoprotein-related multidrug resistance in tumour cells. Br. J. Cancer 73:849-855.
16. Homolya, L., Z. Hollo, U. A. Germann, I. Pastan, M. M. Gottesman, and B. Sarkadi. 1994. Fluorescent cellular indicators are extruded by the multidrug resistance protein. J. Biol. Chem. 268:21493-21496.
17. Jacobsen, H., K. Yasargil, D. L. Winslow, J. C. Craig, A. Kröhn, I. B. Duncan, and J. Mous. 1995. Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959. Virology 206:527-534.
18. Jonsson, B., G. Liminga, K. Csoka, H. Fridborg, S. Dhar, P. Nygren, and R. Larsson. 1996. Cytotoxic activity of calcein acetoxymethyl ester (Calcein/ AM) on primary cultures of human haematological and solid tumours. Eur. J. Cancer 32A:883-887.
19. Kaufmann, D., G. Pantaleo, P. Sudre, and A. Elenti. 1998. CD4-cell count in HIV-infected individuals remaining viremic with highly active antiretroviral therapy (HAART). Lancet 351:723-724.
20. Kim, R. B., M. F. Fromm, C. Wandell, B. Leake, A. J. J. Wood, D. M. Roden, and C. L. Willman. 1998. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J. Clin. Investig. 101:289-294.
21. Kobayashi, Y., N. Watanabe, and K. Oshimi. 1994. Expression of multidrug resistance P-glycoprotein on peripheral blood mononuclear cells of patients with granular lymphocyte-proliferative disorders. Leuk. Lymphoma 14:157-161.
22. Lee, C. G. L., M. M. Gottesman, C. O. Cardarelli, M. Ramachandra, K. T. Jeang, S. V. Ambudkar, I. Pastan, and S. Dey. 1998. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. Biochemistry 37: 3594-3601.
23. Lee, S. C., and B. A. Grabowski. 1998. HIV-1 protease inhibitors and the MDR1 multidrug transporter. J. Clin. Investig. 101:287-288.
24. Lohoff, M., S. Prechtl, F. Sommer, M. Roellinghoff, E. Schmitt, G. Gradehand, P. Rohwer, B. D. Stride, S. P. C. Cole, and R. G. Deely. 1998. A multidrug-resistance protein (MRP)-like transmembrane pump is highly expressed by resting murine T helper (Th)2 cells but not Th1 cells and is induced to equal expression levels in Th1 and Th2 cells after antigenic stimulation in vivo. J. Clin. Investig. 101:703-710.
25. Lorico, A., G. Rappa, R. A. Finch, D. Yang, R. A. Flavell, and A. C. Sartorelli. 1997. Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Res. 57:5238-5242.
26. Lucia, M. B., R. Cauda, A. L. Landay, W. Malorni, G. Donelli, and L. Ortona. 1995. Transmembrane P-glycoprotein (P-gp/P-170) in HIV infection: analysis of lymphocyte surface expression and drug-unrelated function. AIDS Res. Hum. Retroviruses 11:893-901.
27. Middlemas, D., B. K. Kihl, D. Schuetz, L. L. Shu, and P. J. Houghton. A model for doxorubicin resistance in a neuroblastoma cell line is associated with gene amplification and increased functional expression of MDR1. Unpublished data.
28. Shapiro, A. B., and V. Ling. 1997. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. Eur. J. Biochem. 250:130-137.
29. Srinivas, R. V., and J. L. Hurwitz. 1997. HIV growth, inhibition and measurement, p. 1959-1973. In I. Lefkovitz (ed.), The immunology methods manual Academic Press, New York, N.Y.
30. Srinivas, R. V., B. L. Robbins, M. C. Connelly, Y.-F. Gong, N. Bischofberger, and A. Fridland. 1993. Metabolism and in vitro antiretroviral activities of bis(pivaloyloxymethyl) prodrugs of acyclic nucleoside phosphonates. Antimicrob. Agents Chemother. 37:2247-2250.
31. Wang, Q., and W. T. Beck. 1998. Transcriptional suppression of multidrug resistance protein (MRP) gene expression by wild-type p53, abstr. 1147. Proc. Am. Assoc. Cancer Res. Annu. Meet. 39:167.
32. Wijnholds, J., R. Evers, M. R. van Leusden, C. A. Mol, G. J. Zaman, U. Mayer, J. H. Beijnen, M. van der Valk, P. Krimpenfort, and P. Borst. 1997. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nat. Med. 3:1275-1279.
33. Witkowski, J. M., and R. A. Miller. 1993. Increased function of P-glycoprotein in T lymphocyte subsets of aging mice. J. Immunol. 150:1296-1306.
34. Yamamoto, T., T. Iwasaki, N. Watanabe, K. Oshimi, M. Naito, T. Tsuruo, and Y. Kobayashi. 1993. Expression of multidrug resistance P-glycoprotein on peripheral blood mononuclear cells of patients with granular lymphocyte-proliferative disorders. Blood 81:1342-1346.
35. Zaman, G. J., C. H. Versantvoort, J. J. Smit, E. W. Eijdems, M. de Haas, A. J. Smith, H. J. Broxterman, N. H. Mulder, E. G. de Vries, and F. Baas. 1993. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res. 53:1747-1750.